Clinical Trial Results

Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device

N/AOBSERVATIONAL Chicago, Illinois +4 more

RECRUITING

Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

PHASE3INTERVENTIONAL Anaheim, California +4 more

RECRUITING

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

PHASE3INTERVENTIONAL Homewood, Alabama +4 more

RECRUITING

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia

NAINTERVENTIONAL Chicago, Illinois +1 more

RECRUITING

Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)

N/AOBSERVATIONAL Chicago, Illinois

RECRUITING

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

N/AOBSERVATIONAL Atlantis, Florida +4 more

RECRUITING

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

PHASE3INTERVENTIONAL Fullerton, California +4 more

RECRUITING

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

PHASE3INTERVENTIONAL Long Beach, California +4 more

RECRUITING

A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease

PHASE3INTERVENTIONAL Evanston, Illinois

RECRUITING

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

PHASE3INTERVENTIONAL Homewood, Alabama +4 more

RECRUITING

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

PHASE4INTERVENTIONAL Miami, Florida +4 more

RECRUITING